Drug Shortage Report for ORENCIA
| Report ID | 222656 |
| Drug Identification Number | 02402475 |
| Brand name | ORENCIA |
| Common or Proper name | Abatacept |
| Company Name | BRISTOL-MYERS SQUIBB CANADA |
| Market Status | MARKETED |
| Active Ingredient(s) | ABATACEPT |
| Strength(s) | 125MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 4 x 1ml |
| ATC code | L04AA |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-03-18 |
| Estimated end date | 2024-08-01 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-03-19 |
| Company comments | This only affects Orencia SC, the Orencia IV is available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
| Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2024-03-19 | English | Compare |
| v6 | 2024-03-18 | French | Compare |
| v5 | 2024-03-18 | English | Compare |
| v4 | 2024-03-18 | English | Compare |
| v3 | 2024-03-18 | French | Compare |
| v2 | 2024-03-18 | English | Compare |
| v1 | 2024-03-18 | English | Compare |
Showing 1 to 7 of 7